GALECTIN THERAPEUTICS INC — Director's Dealing 2018

Sep 11, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2018-09-07

Reporting Person: OMENN GILBERT S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-07	Common Stock	S	11000	$6.0332	Disposed	56561	Direct
2018-09-10	Common Stock	S	8370	$6.00	Disposed	48191	Direct

Footnotes

F1: The shares were sold in multiple transactions at prices ranging from $6.0131 to $6.05. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.